Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE)
Street 1: Johns Hopkins Center for Tuberculosis Research
Street 2: 1820 Lancaster Street/Suite 300
City: Baltimore
Province: MD
Post Code: 21231
Country: United States of America
Phone: 14432872971
Email: rchaiss@jhmi.edu
Web Site: http://www.tbhiv-create.org

Focal Point Contact Information

Salutation: Dr.
First Name: Richard
Last Name: Chaisson
Title: Principal Investigator
Email: rchaiss@jhmi.edu
Phone: 14432872971

Alternate Focal Point Contact Information

Salutation: Dr.
First Name: Richard
Last Name: Chaisson
Title: Principal Investigator
Email: rchaiss@jhmi.edu
Phone: 14432872971

General Information

Board Constituency: Developed Country NGO
Organization Type - Primary: Non-Governmental Organization
Organization Type - Secondary: Other Non-Governmental Organization (NGO)
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
The Consortium to Respond Effectively to the AIDS/TB Epidemic is a global research and implementation project targeting tuberculosis (TB) control in areas with severe HIV/AIDS epidemics. The purpose of this initiative is to organize, implement and evaluate novel strategies to reduce morbidity and mortality from TB in populations with high rates of HIV and TB co-infection. TB is the leading killer of people with HIV infection worldwide, and the HIV epidemic has seriously undermined TB control efforts in high prevalence areas. While new tools are clearly needed, it is imperative that effective public health strategies are implemented as soon as possible. These strategies will enhance existing control programs and will facilitate future interventions designed to reduce the incidence of morbidity and mortality from HIV-related TB. With funding from the Bill and Melinda Gates Foundation, CREATE will strive to achieve these outcomes over the next 5 to 7 years.
 
Total number of staff in your organization: 11 - 25
Number of full-time staff who are directly involved with TB: 11 - 25
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? Unable to disclose amount
How did you hear about the Stop TB Partnership: Stop TB communications
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: United States of America
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
The work of CREATE has taken place in South Africa, Zambia, and Brazil. Participating organizations in those countries have been broadly interactive with the national departments of health.
 

Geographical Reach

Which country is your headquarters located in: United States of America
Which WHO region is the main focus of your work: African
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Brazil
South Africa
Zambia

Specializations

Advocacy
Research and Development

Specializations in Countries

Research and Development Brazil
Research and Development South Africa
Research and Development Zambia

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB-HIV:
The studies have utilized large-scale strategies to reduce the burden of TB in highly prevalent HIV regions.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date:  
Last updated: June 21, 2012